ZEB2 and breast carcinoma: As a potent inducer of EMT, the role of ZEB2 has been elaborated in various cancers, such as breast carcinoma[68], colorectal carcinoma[69], gynecologic carcinoma[70,71], and lymphoblastic/myeloblastic leukemia[72,73].